IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion
- 28 November 2010
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 152 (2), 182-190
- https://doi.org/10.1111/j.1365-2141.2010.08497.x
Abstract
Summary: Interferon regulatory factor 4 (IRF4) expression is detected in many lymphoid and myeloid malignancies, and may be a promising therapeutic target. IRF4 is strongly expressed in classical Hodgkin lymphoma (cHL) and its expression is up‐regulated by CD40L and down‐regulated by both anti‐proliferative and pro‐apoptotic stimuli. This study analysed the effects of IRF4 silencing in a panel of HL‐derived cell lines. We demonstrated that IRF4 down‐modulation determined a remarkable decrease of both cell number and clonogenic growth in L‐1236, L‐428, KM‐H2 and HDLM‐2 cells, but not in IRF4‐negative L‐540 cells. IRF4 silencing induced apoptosis, as evaluated by caspase‐3 activation and Annexin‐V staining and up‐regulation of the pro‐apoptotic molecule Bax. CD40 engagement by both soluble and membrane bound‐CD40L almost totally reduced IRF4 down‐modulation and growth inhibition by IRF4 silencing in both L‐1236 and L‐428 cells. Finally, IRF4 silencing decreased CCL5 secretion in all HL cell lines tested and CCL17 in KM‐H2 cells. Taken together, our results demonstrated that IRF4 down‐modulation by IRF4 silencing was reversed by CD40 engagement, inhibited HL cells proliferation, induced apoptosis and decreased CCL5 secretion, thus suggesting that IRF4 may be involved in HL pathobiology.Keywords
This publication has 29 references indexed in Scilit:
- Antitumor activity of gold(III)‐dithiocarbamato derivatives on prostate cancer cells and xenograftsInternational Journal of Cancer, 2010
- The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escapeThe Journal of Pathology, 2010
- Functional coexpression of Interleukin (IL)‐7 and its receptor (IL‐7R) on Hodgkin and Reed‐Sternberg cells: Involvement of IL‐7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphomaInternational Journal of Cancer, 2009
- Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactionsInternational Journal of Cancer, 2007
- Expression of CCL5/RANTES by Hodgkin and Reed‐Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissueInternational Journal of Cancer, 2003
- A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cellsBlood, 2000
- On the use of the Kolmogorov-Smirnov statistical test for immunofluorescence histogram comparisonCytometry, 2000
- Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cellsBlood, 1996
- Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's diseaseBlood, 1996
- Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell linesBlood, 1995